(Total Views: 54)
Posted On: 01/07/2025 9:28:29 AM
Post# of 4692
$RAPH Raphael Pharmaceutical Announces Positive Proof-of-Concept Clinical Study Results for the Company’s Cannabinoid-Based Formula for the Treatment of Rheumatoid Arthritis
https://www.globenewswire.com/news-release/20...ritis.html
https://www.globenewswire.com/news-release/20...ritis.html
(0)
(0)Scroll down for more posts ▼
